Loading...

Home
ETF
INMB

INMB

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

INMB News

INmune Bio Hosts Webinar on Alzheimer's Treatment Pathway

Feb 23 2026Newsfilter

INmune Bio to Host CORDStrom Webinar on RDEB Treatment

Feb 19 2026Newsfilter

INmune Bio Receives FDA Support for Alzheimer’s Therapy

Feb 12 2026stocktwits

INmune Bio Publishes Overview on Future Applications of MSC Therapies

Dec 05 2025Globenewswire

INmune Bio Presents New XPro1595 Data for Alzheimer's Disease at CTAD

Dec 01 2025Globenewswire

INmune Bio Successfully Completes Initial Commercial Pilot-Scale Production of CORDStrom™ at CGT Catapult

Sep 15 2025Newsfilter

INmune Bio (INMB) Declines 23.8% Over the Past Month, But a Trend Reversal Could Be Imminent

Sep 08 2025NASDAQ.COM

INmune Bio outlines CORDStrom BLA and MAA filings targeted for mid-2026 as CEO transition highlights strategic shift

Aug 08 2025SeekingAlpha

INmune Bio's CaRe PC Trial of INKmune™ in Metastatic Castration-Resistant Prostate Cancer Meets Endpoints and Is Closed to Enrollment

Aug 04 2025Newsfilter

INmune Bio gains as trial for prostate cancer therapy succeeds

Aug 04 2025SeekingAlpha

INmune Bio Inc. to Report Second Quarter 2025 Financial Results and Provide Corporate Update on Thursday, August 7th

Jul 31 2025Newsfilter

Why Celcuity Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket

Jul 28 2025Benzinga

INmune Bio Rebounds Sharply During After Hours Trading: What's Driving the Surge?

Jul 28 2025Benzinga

INmune Bio to Present Phase 2 MINDFuL Trial Findings of XPro™ at the Alzheimer's Association International Conference

Jul 24 2025Newsfilter

'Pharma Bro' Martin Shkreli Says 'Good Chance' Inmune Bio Stock Will Slip 90% On Monday

Jul 04 2025Benzinga

This Textron Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Jul 01 2025Benzinga